HIV News and Research

RSS

New US headquarters opened by mass photometry pioneers Refeyn

Refeyn, the company behind pioneering mass photometry technologies, has officially opened its new 10,000 sq. ft. US Headquarters and Customer Interaction Center in Waltham’s Biotech Hub in Greater Boston, Massachusetts.

From Refeyn 10 Jun 2024

Fear of stigma and rejection can lead to non-disclosure of STI status

The existing literature on sexually transmitted infection (STI) disclosure.

10 Jun 2024

WHO and FIND join forces to accelerate diagnostic innovation and access

FIND and the World Health Organization (WHO) have signed a new Memorandum of Understanding (MoU) that lays the foundation for accelerating innovation and achieving equitable access to quality diagnostics for people globally.

8 Jun 2024

New study highlights ongoing mpox cases among gay and bisexual men in the U.S.

While mpox cases have sharply declined since the 2022 global outbreak, they continue to occur in the U.S. among gay and bisexual men who have sex with men (GBMSM), according to a UCLA-led study from EMERGEncy ID NET, a multisite surveillance network funded by the Centers for Disease Control and Prevention (CDC).

6 Jun 2024

Complexities and emotional challenges of STI disclosure to sexual partners

A review of research to-date reveals the complex nature of revealing a diagnosis of a sexually transmitted infection (STI) to a partner ahead of engaging in sexual activity.

6 Jun 2024

White House enlists doctors and hospitals to combat gun violence

The White House is calling on hospital executives, doctors, and other health care leaders to take bolder steps to prevent gun violence by gathering more data about gunshot injuries and routinely counseling patients about safe use of firearms.

6 Jun 2024

HPV-based screening key to eliminating cervical cancer in Canada

Implementing human papillomavirus (HPV)-based screening in British Columbia could eliminate cervical cancer in the province before 2040, according to a modeling study in CMAJ.

3 Jun 2024

New strategy targets rare B cells for effective HIV vaccine development

Germline-targeting epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human immunodeficiency virus (HIV).

3 Jun 2024

Cervix-on-a-Chip: A breakthrough model for studying women's health

Bacterial Vaginosis (BV) has been identified as one of the many unmet needs in women's health and affects more than 25% of reproductive-aged women.

30 May 2024

Engineered immunogens show promise in inducing HIV broadly neutralizing antibodies

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing antibodies (bNAbs).

30 May 2024

New antibody shows promise as universal weapon against COVID-19 variants

SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions.

29 May 2024

Foam-based delivery system could revolutionize gene therapies

Foam mixed with medications is already used to treat conditions such as varicose veins, hemorrhoids, wounds on the skin and even hair loss.

29 May 2024

FDA urged to relax decades-old tissue donation restrictions for gay and bisexual men

The federal government in 2020 and 2023 changed who it said could safely donate organs and blood, reducing the restrictions on men who have had sex with another man.

24 May 2024

77th World Health Assembly to address global health challenges under 'All for Health, Health for All'

As the world continues to grapple with the aftermath of the most severe pandemic in a century, the Seventy-seventh session of the World Health Assembly will convene under the banner of "All for Health, Health for All."

22 May 2024

WHO report highlights rising STI rates and insufficient progress in HIV and hepatitis control

Global HIV, viral hepatitis epidemics and sexually transmitted infections (STIs) continue to pose significant public health challenges, causing 2.5 million deaths each year, according to a new WHO report - Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030.

22 May 2024

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS’ CRISPR/Cas9 patent portfolio.

From ERS Genomics 21 May 2024

Breakthroughs in germline-targeting HIV vaccine design for broad protection

Scientists have made several advances in the design of a class of HIV vaccines that could offer broad protection against the virus, according to four new research papers published this week in Science, Science Translational Medicine, and Science Immunology.

17 May 2024

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

17 May 2024

Clean needles save lives. In some states, they might not be legal.

Kim Botteicher hardly thinks of herself as a criminal. On the main floor of a former Catholic church in Bolivar, Pennsylvania, Botteicher runs a flower shop and cafe.

17 May 2024

Experimental gene therapy shows promise for treating herpes infections

Researchers at Fred Hutch Cancer Center have found in pre-clinical studies that an experimental gene therapy for genital and oral herpes removed 90% or more of the infection and suppressed how much virus can be released from an infected individual, which suggests that the therapy would also reduce the spread of the virus.

13 May 2024